Literature DB >> 35747452

TAVR for severe aortic stenosis and papillary fibroelastoma in a high-risk setting.

Ishtiaq Rahman1, Ammar Alibrahim2, Mohammad Zahrani2, Joji Ito2, Kim Connelly3, Chris Buller4, Mark Peterson5, David Latter6.   

Abstract

Papillary fibroelastomas (PFE) are rare benign cardiac tumours mainly originating on aortic and mitral valvular surfaces. Management is individualised, but most recommend surgical excision due to thromboembolic risk. We report a 75-year-old man with symptomatic severe aortic stenosis compounded by PFE. Redo sternotomy aortic valve replacement was deferred in favour of the trans-apical (TAVR) approach. This report highlights, for the first time, the application of TAVR as a strategy for aortic valve stenosis and PFE to mitigate risk posed by injury to patent internal mammary arterial graft in close proximity to the manubrium, and complications due to the patient's multiple comorbidities.
Copyright © 2021 Medinews (Cardiology) Limited.

Entities:  

Keywords:  aortic valve stenosis; heart neoplasm; transcatheter aortic valve replacement (TAVR)

Year:  2021        PMID: 35747452      PMCID: PMC8822510          DOI: 10.5837/bjc.2021.023

Source DB:  PubMed          Journal:  Br J Cardiol        ISSN: 0969-6113


  2 in total

1.  Papillary fibroelastoma of the aortic valve: analysis of 21 cases, including a presentation with cardiac arrest.

Authors:  Hirohisa Ikegami; Adin-Cristian Andrei; Zhi Li; Patrick M McCarthy; S Chris Malaisrie
Journal:  Tex Heart Inst J       Date:  2015-04-01

2.  Slowly growing cardiac tumor: a case of fibroelastoma.

Authors:  S Ayabe; K Hara; I Yamazaki; E Toda; T Tamura
Journal:  J Cardiol       Date:  2000-08       Impact factor: 3.159

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.